Mouse and human CPCs were isolated using c-kit beads from Milthenyi as described recently. 16, 17 Please find a detailed protocol in the online-only Data Supplement. For small interfering RNA (siRNA) knockdown, HiPerfect (Qiagen) was used according the manufacturer's instructions. Three hundred thousand cells were plated in 10-cm dishes, and full medium was replaced by DMEM-F12 supplemented with 2.5% fetal bovine serum to slow down expansion and allow knockdown. Twenty-four hours after siRNA treatment,
C ardiac progenitor cells (CPCs) show promise in early clinical trials for treatment of ischemic cardiomyopathy, despite limited mechanistic knowledge of the endogenous regenerative response after myocardial infarction (MI). 1, 2 A better understanding of the endogenous repair mechanisms will open up novel treatment options circumventing difficulties associated with cell-based transplantation approaches.
Under normal conditions in healthy myocardium, CPCs reside within the cardiac niche but expand quickly upon activating stimuli resulting from tissue injury, such as MI. 3, 4 CPC numbers are also elevated during early development but decline throughout progression from postnatal maturation to adulthood. 5, 6 Composition of extracellular matrix undergoes dramatic changes during both MI and development. 7 Within the families of extracellular matrix molecules, fibronectin (Fn) shows circumstantial correlations with CPC activities because Fn is highly expressed in early development, remains low in healthy adult tissue, and is increased enormously after injury. [8] [9] [10] Furthermore, Fn has been described recently as component of the cardiac stem cell niche in the adult mammalian heart. 11 Also, CPCs are capable of secreting Fn after isolation in vitro. 12 Collectively, these findings point to a role for Fn in regulation of CPC biology, but this question has not been addressed in prior studies.
Constitutive Fn knockout is embryonically lethal as a result of cardiovascular malformation in mice and zebra fish. [13] [14] [15] Therefore, a conditional Fn knockdown mouse was established by our group to define the role of Fn for the endogenous CPC response and concomitant healing processes in a murine MI model. experiments were started. Only validated siRNAs were used from ≥2 different companies at 25 nmol/L final concentration (Applied Biosystem, Sigma-Aldrich or Bioneer). For experiments using pharmacological inhibitors, cells were preincubated for 30 minutes before the start of the experiment. Ly294002 (phospho inositide 3-kinase [PI3K] inhibitor, 50 µmol/L) and focal adhesion kinase (FAK) inhibitor II (100 nmol/L) were from Sigma-Aldrich; quercetagetin (Pim1 inhibitor, 10 µmol/L), Akt V inhibitor (10 µmol/L), and signal transducer and activator of transcription 3 (STAT3) inhibitor (10 µmol/L) were from Calbiochem.
Animals
To create inducible Fn knockdown animals, mice expressing tamoxifen sensitive Cre under cytomegalovirus-enhanced global actin promoter (Cre +/− , Jackson, No. 004682) were crossed for 2 generations with homozygous floxed finronectin mice (Fn fl/fl , generously provided by Prof Dr Reinhard Fässler). 18 The obtained mice (Cre +/− Fn fl/fl ) were bred with Fn fl/fl animals for multiple generations to build up the colony. Both mice strains have a C57BL/6 background. At the age of 8 weeks, all mice received tamoxifen intraperitoneally for 10 days 1 mg/d resuspended in a 1:10 mixture of 100% ethanol in sunflower oil to induce recombination. Cre +/− Fn fl/fl mice were considered knockout animals, whereas Cre-negative littermates represent controls. As we are also aware of the potential transient side effects caused by Cre activation in the heart, we have included a second control group in the primary functional echocardiographic study consisting of the Cre-expressing mouse strain (No. 004682) without floxed Fn alleles (control 2). This group was treated with tamoxifen and surgical procedures identically to the study groups and assessed by echocardiographic analysis (Online Table I ). No significant difference was observed between the 2 control groups, so subsequent biochemical and immunohistochemical analyses were performed using the Fn fl/fl mice as control only, because they are genetically closest to the KO group stemming from the same breeder pairs. Pim1 KO animals were described recently. 19 All animal procedures and treatments were approved by the Institutional Animal Care and Use Committee of San Diego State University.
Surgical Procedures and Echocardiographic and Invasive Hemodynamic Assessment
Twelve-week-old female animals were anesthetized under isoflurane 2%, intubated, and ventilated. A thoracotomy was performed and the left anterior coronary artery ligated. Successful infarction was confirmed by echocardiography. Consecutive noninvasive assessment of cardiac function in the parasternal long axis view has been performed 1, 2, 4, 6, 8, and 12 weeks after surgery. Echocardiographic and invasive hemodynamic assessment of function, as well as surgery and data analysis, were performed in a blinded fashion. Closed chest hemodynamic assessment was performed on mice anesthetized with 3% chloralhydrate (10 µL per 1 mg body weight) before insertion of microtip pressure transducer (FT111B, Scisense) into the right carotid artery and advancement into left ventricle. The catheter was connected to an A/D converter (FV892A, Scisense) for data collection. Echocardiography was performed under mild isoflurane sedation (0.5%-1.5%) using a Vevo 770 high-resolution system. Cardiac function was analyzed in the parasternal long axis view by tracking the endocardium with the supplied analysis software to obtain end systolic volume, end diastolic volume, ejection fraction, and heart rate. After hemodynamic measurements, hearts were arrested in diastole using high potassium solution and perfused with phosphate-buffered formalin for 15 minutes (Sigma-Aldrich) via retrograde cannulation of the abdominal aorta. Retroperfused hearts were removed from the chest cavity and placed in formalin for at least another 24 hours. Alternatively, after hemodynamic assessment hearts were removed directly and frozen down in liquid nitrogen until further processing.
Immunohistochemistry
Please find a detailed protocol in the online-only Data supplement.
Antibodies
Please find a complete list of applied antibodies in the online-only Data Supplement (Online Table II ).
Adhesion, Cell Death, and Proliferation Assays
Cell viability was assessed using the Annexin V kit from BD combined with 7-amino-actinomycin D or propidium iodide staining according the manufacturer's instructions. Briefly, CPCs were plated on BSA-or Fn-coated dishes, and cells were allowed to adhere overnight. On the next day, stress stimuli were applied (staurosporine: 2.5 ng/mL in medium without growth factors supplemented with 2.5% fetal bovine serum; starvation: medium without growth factors and no serum supplementation), and the next day complete content of each dish was collected (detached dead cells as well as adherent cells). Cells were pelleted and resuspended in the supplied staining buffer. After another wash step, cells were stained with annexin V and the nuclear dye in staining buffer. Data were acquired on a FACS Canto or FACS Aria from BD and analyzed with FACS Diva software from BD.
Cell proliferation was determined using the CyQuant proliferation assay from Invitrogen according the manufacturer's instruction. Briefly, 1000 CPCs in 100 μL per well were seeded in a 96-well flat bottom plate, which was precoated with Fn or BSA as control. Assay was initiated by addition of 100 μL of CyQUANT direct (Invitrogen) green fluorescent nucleic acid stain in each well and incubated for 30 minutes. Green fluorescence intensity was measured at 495 nm using a plate reader and represented as fold change to the fluorescence intensity measured on the day of plating (day 0, ≥8 hours after plating). Subsequent measurements were determined at the indicated days.
Plate-based adhesion assays were performed as published recently. 20 In brief, Fn coating of 96-well plates was performed as described, and then 3000 cells/well were added in 100 µL full medium and allowed to adhere for 24 hours. Nonattached cells were removed with a wash, and wells were filled up to capacity and sealed. Plates were inverted, and nonadherent cells were allowed to sink. Supernatant containing nonadherent cells was removed, and cells were quantified using CyQuant solution. Adherent cells are depicted as percentage cells relative to overall cell input.
Sample Preparation, Immunoblotting, and Reverse Transcriptase Polymerase Chain Reaction
Whole heart and isolated cell lysates were prepared as described recently. 19 Please find more details in the online-only Data supplement.
Statistics
Statistical analysis was performed using GraphPad Prism 5.0 (Graphpad Software Inc; www.graphpad.com). P<0.05 were considered significant. To compare 2 groups with normal distribution, Student t test was applied; otherwise a nonparametric test was used. For comparison of >2 groups, 1-way ANOVA was applied and for the echocardiographic time course analysis, 2-way ANOVA was used; in both cases Bonferroni post hoc tests were included.
Results

Fibronectin Expression Correlates With CPC Expansion During Development and After MI
The spatiotemporal correlation of CPC presence with Fn expression was assessed to establish that these phenomena are linked to development and infarction injury. CPCs are present in high numbers in young postnatal hearts and decline during development. 5,6,21 Therefore, expression of Fn and c-kit was quantified in whole hearts in a time course analysis using Figure 1A ). Immunohistochemical examination of developmental myocardial sections showed close proximity of Fn with CPCs ( Figure 1A ). MI induces a transient rise of CPCs in response to injury. Corroborating these findings, Fn expression level correlated with c-kit induction of both mRNA and protein.
As during development, CPCs were found in close proximity with Fn in the infarcted area and in the border zone ( Figure 1B ). Loss of Fn attenuates endogenous CPC response after MI, correlating with progressive decline of cardiac function during follow-up. Because nonconditional knockout of Fn is embryonically lethal with cardiovascular malformation, we established a conditional Fn knock out strain that can develop normally throughout postnatal development into adulthood. Fn is a ubiquitous extracellular matrix protein that is produced in multiple cell types, necessitating the use of a global Cre promoter to ensure appropriate reduction of expression during the relatively short time course of experimental design in adult mice. Mice possessing heterozygous expression of tamoxifen sensitive Cre under a cytomegalovirus-enhanced βactin promoter were crossed with mice carrying a floxed Fn gene, leading to loss of Fn expression after tamoxifen induced recombination (knockout animals, KO). At the age of 8 weeks, when physiological development was completed, tamoxifen was injected for 10 days in KO and controls. At the age of 12 weeks, both groups underwent sham or MI surgery. The 4-week window allowed recombination and consecutive loss Figure I ). 22, 23 Echocardiography was performed in all animals to assess cardiac function before inclusion in the study to exclude preexisting impairment. Cardiac function remained comparable in the Fn-KO animals compared with controls over the course of normal aging for ≥1 year (data not shown). Induction of Fn mRNA was robust in the MI area of control animals as previously shown ( Figure 1B) . In comparison, Fn expression in KO mice was reduced at baseline under sham conditions, and induction of Fn after MI was attenuated at 7 days in the remote as well as the infarction area (Figure 2A) . As a correlate for plasma Fn, gene expression of Fn in hepatic tissue was quantified, showing ≈50% reduction in the global knockout model before and after MI (Online Figure I) . Cardiac function in control and KO mice declined after MI and remained equivalent ≤2 weeks after MI. However, by 4 weeks, heart function in KO mice worsened compared with control mice as evidenced by ejection fraction values measuring 16% versus 28% at 12 weeks after MI ( Figure 2B ). End diastolic volume and heart rate were not different between groups after MI.
End systolic volume tended to be smaller in control mice not reaching significance (Online Figure I) . Invasive hemodynamic assessment at the end of the follow-up period confirmed these data as positive and negative developed pressure were significantly impaired in the KO animals ( Figure 2B ). Also, the heart weight to body weight ratio, as well as end diastolic pressure, was higher in KO animals compared with controls 12 weeks after MI ( Figure 2C and Online Figure I ).
Next, we analyzed the endogenous CPC response to MI in normal versus KO mice. mRNA expression of c-kit was reduced in heart lysates of KO animals 7 days after MI, suggesting impaired CPC expansion on Fn knock out (Figure 2A ). On the single-cell level using immunohistochemistry, c-kit + CPC number was reduced by 43.3% in KO mice ( Figure 3A and 3B; low magnification in Online Figure II ). Costainings of tryptase or CD45, together with c-kit + , showed very infrequent colocalization with c-kit+ cells, excluding significant interference by coincident mast cells (Online Figure II) . Remarkably, the few remaining CPCs observed in sections from KO hearts remain in close proximity to residual Fn after knockout. To analyze the mechanism leading to reduction of CPC number, immunolabeling for Ki67 (a cellular proliferation marker) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were performed. TUNEL staining revealed increased apoptotic CPC death in KO mice (5.54±1.24%) versus controls (1.99±0.35%; Figure 3D ). CPC proliferation measured by Ki67 labeling was increased in control mice expressing Fn (33±1.99%) relative to KO mice (19.9±4.28%; Figure 3E ). At this 1-week post-MI early time point, the infarct size was comparable between both groups ( Figure 3C ), and no differences were observed in gene expression for markers of inflammation, remodeling, or fibrosis between the groups (Online Figure II) .
Loss of Fn Attenuates Repair of Vessels and Cardiomyocytes and Correlates With Impaired CPC Expansion
Proliferating cells were labeled by bromodeoxyuridine incorporation that was delivered systemically for 10 days after MI when the CPC population was expanding. The presence of BrdU + cells incorporated into newly formed committed cell structures were quantified 12 weeks later by costaining for BrdU with sarcomeric actin (cardiomyocytes), isolectinB4 (endothelial cells), or SM22 (vascular smooth muscle cells). BrdU + cardiomyocytes were reduced by 68.07% and newly formed BrdU + vascular smooth muscle cells by 16.56% in KO mice compared with control animals. BrdU + endothelial cell number was unchanged. Congruent with these findings, the density of small arteries was also reduced by 24.19%, whereas capillary density was unchanged. Newly formed BrdU + cardiomyocytes normalized to the analyzed area were also reduced by 66.6% in KO mice ( Figure 4A and 4B) . Infarct size at the 12-week time point was significantly larger in KO animals compared with controls ( Figure 4C ).
Fn Induces Protection and Proliferation via α 5 β 1 Integrin in CPCs
To test whether Fn has direct functional impact on CPC biology, CPCs were plated in vitro on dishes coated with Fn or BSA as a control. CPCs were stressed by either serum starvation or staurosporine treatment for 16 hours, and resultant cell death was quantified using nuclear staining with 7-aminoactinomycin D and annexin followed by fluorescence-activated cell sorter analysis. Either stress condition resulted in ≈35% of CPCs positive for 7-amino-actinomycin D and annexin on BSA-coated plates. In comparison, ≈20% of the cells cultured with Fn underwent apoptosis ( Figure 5A ). Main cellular receptors for Fn belong to the integrin family of proteins. Of the 24 described integrin receptors, 13 are known to bind Fn (Online Figure III , taken out of a review by Hynes). 24 Apart from heterodimers αIIbβ 3 (typically expressed on platelets) and α 4 β 7 (mainly expressed on leukocytes), the remaining 11 receptors consist either of the α V -chain (in conjunction with β 3 , β 5 , β 6 , β 8 , or β 1 ) or the β 1 -chain (in conjunction with α 2 , α 3 , α 4 , α 5 , α 8 , α 9 , or α V ). Therefore, siRNA interference was used to selectively knock down α V -or β 1 -chain and thereby narrow in on the responsible receptor for Fn-mediated CPC protection by repeating the apoptosis experiments. Fn-dependent protection was completely blocked by β 1 knockdown ( Figure 5B ) with either stress condition, whereas α V knockdown had no effect on Fn-mediated protection (Online Figure III) . α 4 and α 5 integrins are the most likely candidates to cooperate with β 1 because they are known to be important for cardiovascular development. 24 Integrin α 4 expression could not be found on CPCs in vitro (data not shown); therefore, integrin α 5 was knocked down, and the protection experiment was repeated. siRNA knockdown of integrin α 5 partially prevented Fninduced protection under either stress conditions ( Figure 5C ), thereby identifying α 5 β 1 as a responsible integrin heterodimer.
Decreased Ki67 expression in vivo in Fn-KO animals ( Figure 3 ) prompted assessment of Fn on CPC proliferation. Cell growth in vitro was also assessed with coated dishes as described for the aforementioned protection studies. CPCs plated on Fn showed accelerated expansion, leading to 1.56× more cells after 5 days in culture ( Figure 5D ). As previously described for the protection studies ( Figure 5A-5C ), integrin receptor interference by siRNA showed that α V knockdown did not block proliferation, whereas β 1 knockdown completely abolished cell growth ( Figure 5D ). Also, α 5 knockdown attenuated Fn-induced proliferation ( Figure 5D ). Expression of the integrin α 5 β 1 heterodimer expression was confirmed on CPCs in vivo by confocal microscopy ( Figure 5E ). Successful knockdown of the individual integrin chains was confirmed on mRNA and protein level (Online Figure III) . Furthermore, knockdown of α 5 had no impact on β 1 expression and vice versa (Online Figure III) . Also, additive effects were not evident when knocking down both α 5 and β 1 integrin together (data not shown). Therefore, heterodimer α 5 β 1 is the responsible receptor mediating proliferation and protection of CPCs on Fn treatment. Neither of the 2 subchains is mediating its effect by indirectly regulating expression of the other subunit. Furthermore, integrin knockdown had no significant impact on adhesion of CPCs at the start of stress stimulation (Online Figure III) . Recently, we published that fenoterol induces significant proliferation of CPCs. 25 However, Fn treatment is a more potent proliferative stimulus, and there is no additive effect detectable when fenoterol is given together with Fn (Online Figure III) .
Pim1 Mediates Fn-Induced Protection and Proliferation in CPCs
Recently, the constitutive active serine/threonine kinase Pim1 has been identified as a main downstream mediator of protective Akt signaling in cardiomyocytes. 19 Furthermore, Pim1 overexpression induces proliferation in CPCs. 16 Consistent with results shown in Figure 1 , Pim1 expression decreases during physiological development and is reinduced after MI (Online Figure IV) . 19 Involvement of Pim1 signaling in CPC survival and proliferation after Fn treatment was assessed on mRNA and protein levels. Strikingly, Fn treatment of CPCs induced Pim1 transcription and protein expression ( Figure 6A) . The protective effect of Fn is tied to Pim1 induction, as Pim1 blockade by either pharmacological (Figure 6C , by preincubation with quercetagetin) or genetic ( Figure 6D , by siRNA-mediated downregulation of Pim1) intervention eliminated the protective effect of Fn as measured by cell death assay. Successful knockdown of Pim1 was confirmed by reverse transcriptase polymerase chain reaction and immunoblot (Online Figure IV) . Furthermore, Pim1 inhibition also blocked Fn-induced proliferation (Online Figure IV) . Because β1 integrin is the responsible receptor for protective signaling after Fn treatment ( Figure 5 ), this receptor was knocked down, and Pim1 expression analysis after Fn treatment was assayed. Knockdown of β 1 integrin abolished Fn-dependent induction of Pim1 on mRNA and protein levels ( Figure 6E ). Control studies confirmed that Pim1 overexpression protects CPCs from apoptosis induced by stress challenge (Figure 6B) , as confirmed by MI challenge in Pim1 knock out animals (Pim1-KO) and respective FVB controls. CPC response at day 7 after MI was quantified using immunohistochemistry in conjunction with TUNEL staining as done before for Fn-KO mice. c-kit + cell number was reduced by 63% in Pim1-KO compared with control animals (Online Figure IV) . In FVB controls, 0.69±0.3% of CPCs were TUNEL positive, whereas in Pim1-KO animals 3.27±1.1% stained TUNEL positive.
Prior studies in the nonmyocardial context demonstrate integrin signaling via FAK and PI3K to activate Akt, which is known to be upstream of Pim1. Alternatively, Aktindependent induction of Pim1 occurs via Stat3 signaling. 19, 26 The signaling cascade, leading from Fn stimulation to Pim1 induction, was assessed by pretreatment with FAK inhibitor II, Ly294002 (PI3K inhibitor) and Akt inhibitor V before culture on Fn substrate. FAK inhibitor II completely blocked Pim1 
Discussion
Results presented in this report demonstrate that Fn is crucial for endogenous CPC responses and consecutive healing processes after MI in mice. Fn induces proliferation and protection of CPCs in vivo and in vitro via β 1 integrin-FAK-Stat3-Pim1 pathway independent of Akt. Furthermore, relevance for human CPC biology is underscored by key experiments in vitro using CPCs obtained from cardiac surgery patients. Loss of Fn in vivo leads to impaired CPC expansion after MI and consecutive reduced endogenous regeneration evidenced by diminution of newly formed cardiomyocytes and vessels correlating with further deterioration of cardiac function during follow-up.
Induction of Fn expression after tissue injury, 9 as well as the expansion of cardiac resident stem cells after MI, has been previously documented. 3 However, our findings are the first to our knowledge that causally link Fn expression to CPC expansion in a beneficial fashion for post-MI recovery. In contrast, Fn has been previously associated with fibrosis and adverse effects of the heart than repair or regeneration. 27 Paradoxically, mice lacking the embryonic Fn splice variant extra type III domain A show reduced inflammatory response correlating with improved cardiac function after experimental MI. 28 However, in our model no change in the expression of inflammatory, fibrosis, or remodeling markers was evident. This discrepancy might be explained by compensatory upregulation of other splice variants and concomitant changes in inflammation as noted in this prior study. Alternatively, the discrepancy may be based solely on variation in the genetic backgrounds of the mouse strains analyzed or differences in sex. In the present study, female mice were used because female mice exhibit a more pronounced CPC response to MI. 29 The ultimate reconciliation of these disparate findings will require more extensive analysis in future studies. Another limitation of the study is that we cannot specify the source of Fn. Plasma-derived soluble Fn, as well as intracardially secreted cellular Fn, is downregulated in the global knock out model. Further experiments are needed to determine the contribution of each type of Fn to the overall Fn response.
Proproliferative effects of Fn have been established in other cell types, for example, adipose-derived progenitor cell, 30 with downstream signaling predominantly through the PI3K-Akt axis. In the cardiac context, Pim1 has been established as the main downstream mediator of Akt-mediated cardioprotection. 19 Our results extend these initial findings by demonstrating a novel β 1 integrin-FAK-Stat3-Pim1 pathway independent of Akt in CPCs. Whether Pim1 mediates protection in CPCs on Fn stimulation via bcl family proteins and subsequent preservation of mitochondrial integrity as described in cardiomyocytes is the topic of ongoing research. 31 However, the transient nature of Fn expression after MI that falls to preinjury levels within 1 month 32 limits impact of Fn for maintenance of Pim1 activity to enhance long-term myocardial repair. The beneficial effect of chronic Pim1 activation in CPCs leading to enhanced regeneration has been documented in both mouse 16 and human 17 CPCs. Therefore, we speculate that extended therapeutic activation of Pim1 signaling cascade via Fn by either small-molecule receptor-ligand binding or gene therapy to extend the temporal expression of Fn in the heart will lead to enhanced endogenous CPC-mediated repair. Studies to examine the utility of enhanced Fn expression in the post-MI remodeling process are underway in our laboratory.
Improving myocardial regeneration and repair by increasing the number of CPCs in the infarcted heart has been proven by multiple studies from various groups that injected and tracked ex vivo expanded c-kit + CPCs. 3, 16, 33 Also, initial clinical trials with 2 years of follow-up show robust improvement of function after c-kit + stem cell injection. 1 Although endogenous CPCs residing in the border zone after MI are unable to improve cardiac function, interference with the endogenous stem cell response correlates with further deterioration of cardiac function over time as shown in this report. We posit that the endogenous CPC response participates in stabilizing function after tissue loss. Although a relative change in the number of CPCs by 43% is substantial, the impact on functional outcome is comparatively low. However, absolute numbers of endogenous CPCs are low, and expectations of robust functional recovery derive from studies where exogenous expanded CPCs are injected in supraphysiological high numbers into the scar. Another explanation might be that Fn as an extracellular molecule could also provide salutary effects, in addition to CPC recruitment, which would be reduced in the KO mice, contributing to impairment of cardiac function. Limited reparative responses quantified as BrdU + cardiomyocytes and vessel structures were reduced in KO compared with control mouse hearts. This minor impairment alone may not fully explain the worsening of cardiac function in the KO line, although no differences could be found related to either inflammation or remodeling. Indeed, the CPC-dependent reparative response quantified as BrdU + committed cells will be underestimated because BrdU administration was limited to the first 10 days after MI as a result of toxic side effects. Although we observed reduction in vascular structures measured as smooth muscle actin-positive arteries, further functional assays, such as coronary flow analysis, are needed in future studies to establish functional relevance. The possibility remains that other c-kit − progenitor populations or cardiomyocyte proliferation contributes to the reparative response, which cannot be excluded by our results. Noteworthy in this context, the most robust Fn expression and CPC expansion were observed in epicardial and border zones, whereas BrdU-labeled myocytes were predominantly found in the penumbra of the MI within ventricular wall parenchyma and endocardial layers. Also, Fn could play a role in commitment toward meso-endodermal differentiation as shown for embryonic stem cells. 34 Nevertheless, findings presented here convincingly demonstrate that Fn is essential for CPC response and repair, and impairment of CPCmediated regeneration contributes at least partially to the observed detrimental effects of Fn deletion on cardiac function. Clearer answers regarding the role of the c-kit + population in endogenous myocardial repair will be obtained using a c-kitdriven inducible conditional reporter mouse line currently under construction that will be used in future studies. In addition, therapeutic induction of Fn in the heart, temporally coupled to the regenerative response after MI challenge, is being explored at present in our group using a systemic Fn fragment administration leading to collagen-targeted delivery to demonstrate the impact of local Fn accumulation on CPC response and circumvent interpretative limitations inherent in a global KO mouse model.
Taken together, we show that Fn is essential for the endogenous CPC response after MI, mediating CPC proliferation and protection through a novel β 1 integrin-FAK-Stat3-Pim1 pathway ( Figure 7) . Future studies will refine our understanding of Fn in directing the endogenous regenerative and reparative response, which eventually will provide insight toward rational design of therapeutic interventional strategies to enhance endogenous regeneration in conjunction with or without the need for ex vivo autologous cell expansion. 
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